Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.
Ontology highlight
ABSTRACT: The biological role of interleukin-37 (IL-37) in cancer is large unknown. Through immunohistochemical detection using 163 primary hepatocellular carcinoma (HCC) clinical specimens, we found the expression of IL-37 was decreased in tumor tissues, and the expression level was negatively correlated with tumor size. High expression of IL-37 in HCC tumor tissues was associated with better overall survival (OS) and disease-free survival (DFS). IL-37 expression in tumor tissues was positively associated with the density of tumor-infiltrating CD57+ natural killer (NK) cells, but not with the CD3+ and CD8+ T cells. Consistently, in vitro chemotaxis analysis showed that IL-37- overexpressing HCC cells could recruit more NK cells. The in vivo mouse model experiments also revealed that overexpression
SUBMITTER: Zhao JJ
PROVIDER: S-EPMC4046124 | biostudies-literature | 2014 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA